Biome Australia Limited (ASX:BIO)
Australia · Delayed Price · Currency is AUD | Market Cap | 84.36M -19.5% |
| Revenue (ttm) | 23.88M +29.7% |
| Net Income | 3.61M +1,580.9% |
| EPS | 0.02 +1,519.0% |
| Shares Out | 228.00M |
| PE Ratio | 23.27 |
| Forward PE | 23.13 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 296,274 |
| Open | 0.3550 |
| Previous Close | 0.3550 |
| Day's Range | 0.3550 - 0.3800 |
| 52-Week Range | 0.2000 - 0.5250 |
| Beta | 0.99 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 20, 2026 |
About Biome Australia
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and nutraceutical and complementary medicines under the Activated Therapeutics brand. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Aus... [Read more]
Financial Performance
In fiscal year 2026, Biome Australia's revenue was 23.88 million, an increase of 29.68% compared to the previous year's 18.42 million. Earnings were 3.61 million, an increase of 1580.93%.
Financial StatementsNews
Biome Australia Slides: Investor presentation
Biome Australia has posted slides in relation to its latest quarterly earnings report, which was published on September 14, 2026.
Biome Australia Earnings Call Transcript: Q4 2026
FY 2026 saw record revenue, cash generation, and market leadership, with strong growth in both domestic and international markets. Strategic milestones included onshore manufacturing, proprietary IP development, and a digital health initiative, positioning for accelerated growth in FY 2027.
Biome Australia Earnings release: Q4 2026
Biome Australia released its Q4 2026 earnings on August 2, 2026, summarizing the period's financial results.
Biome Australia Slides: Investor presentation
Biome Australia has posted slides in relation to its latest quarterly earnings report, which was published on July 26, 2026.
Biome Australia Transcript: Status update
Record H1 results with 40% revenue growth and strong profitability were highlighted, alongside a strategic shift to onshore manufacturing expected to boost margins and working capital. Product innovation, robust clinical backing, and expansion in Australia and abroad underpin a positive outlook.
Biome Australia Slides: Status update
Biome Australia has posted slides in relation to its latest quarterly earnings report, which was published on June 4, 2026.
Biome Australia Earnings release: Q3 2026
Biome Australia released its Q3 2026 earnings on April 28, 2026, summarizing the period's financial results.
Biome Australia Earnings Call Transcript: H1 2026
Record H1 2026 revenue and profit growth driven by premium practitioner-only model, strong gross margins, and expanding distribution. International expansion and proprietary clinical pipeline support long-term growth, with disciplined capital management and no retail price increases since 2019.
Biome Australia Quarterly report: H1 2026
Biome Australia has published its H1 2026 quarterly earnings report on February 24, 2026.
Biome Australia Slides: H1 2026
Biome Australia has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 24, 2026.
Biome Australia Earnings release: H1 2026
Biome Australia released its H1 2026 earnings on February 24, 2026, summarizing the period's financial results.
Biome Australia Earnings release: Q2 2026
Biome Australia released its Q2 2026 earnings on January 27, 2026, summarizing the period's financial results.
Biome Australia Transcript: AGM 2025
Record attendance marked a year of strong growth, with sales up 41% and net profit achieved. Key resolutions on remuneration, director re-election, share issues, and expansion plans were passed. International growth and new product launches position the company for continued success.
Biome Australia Earnings Call Transcript: Q1 2026
Record Q1 FY 2026 with $24M annualized sales, $462K EBITDA, and 84% YoY cash receipts growth. International expansion in Canada, Ireland, and New Zealand is accelerating, while gross margin remains above 61% and new product launches drive further growth.
Biome Australia Earnings release: Q1 2026
Biome Australia released its Q1 2026 earnings on October 22, 2025, summarizing the period's financial results.